A common drug against the human immunodeficiency virus (HIV), the dolutegravir was modified to become a series of dolutegravir-1,2,3-triazole derivatives.
[Bioorganic Chemistry]
Discovery of Dolutegravir-1,2, 3-Triazole Derivatives against Prostate Cancer via Inducing DNA Damage
